Cargando…

A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency

Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems important to develop the best practice gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Speiser, Phyllis W., Azziz, Ricardo, Baskin, Laurence S., Ghizzoni, Lucia, Hensle, Terry W., Merke, Deborah P., Meyer-Bahlburg, Heino F. L., Miller, Walter L., Montori, Victor M., Oberfield, Sharon E., Ritzen, Martin, White, Perrin C.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963799/
https://www.ncbi.nlm.nih.gov/pubmed/20981249
http://dx.doi.org/10.1155/2010/494173
_version_ 1782189314266890240
author Speiser, Phyllis W.
Azziz, Ricardo
Baskin, Laurence S.
Ghizzoni, Lucia
Hensle, Terry W.
Merke, Deborah P.
Meyer-Bahlburg, Heino F. L.
Miller, Walter L.
Montori, Victor M.
Oberfield, Sharon E.
Ritzen, Martin
White, Perrin C.
author_facet Speiser, Phyllis W.
Azziz, Ricardo
Baskin, Laurence S.
Ghizzoni, Lucia
Hensle, Terry W.
Merke, Deborah P.
Meyer-Bahlburg, Heino F. L.
Miller, Walter L.
Montori, Victor M.
Oberfield, Sharon E.
Ritzen, Martin
White, Perrin C.
author_sort Speiser, Phyllis W.
collection PubMed
description Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems important to develop the best practice guidelines for treating not only infants and children, but affected adults as well. This report gives a brief overview of the most recent expert opinion and clinical practice guidelines for CAH as formulated by The Endocrine Society Task Force.
format Text
id pubmed-2963799
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-29637992010-10-27 A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency Speiser, Phyllis W. Azziz, Ricardo Baskin, Laurence S. Ghizzoni, Lucia Hensle, Terry W. Merke, Deborah P. Meyer-Bahlburg, Heino F. L. Miller, Walter L. Montori, Victor M. Oberfield, Sharon E. Ritzen, Martin White, Perrin C. Int J Pediatr Endocrinol Commentary Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems important to develop the best practice guidelines for treating not only infants and children, but affected adults as well. This report gives a brief overview of the most recent expert opinion and clinical practice guidelines for CAH as formulated by The Endocrine Society Task Force. Hindawi Publishing Corporation 2010 2010-06-30 /pmc/articles/PMC2963799/ /pubmed/20981249 http://dx.doi.org/10.1155/2010/494173 Text en Copyright © 2010 Phyllis W. Speiser et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Speiser, Phyllis W.
Azziz, Ricardo
Baskin, Laurence S.
Ghizzoni, Lucia
Hensle, Terry W.
Merke, Deborah P.
Meyer-Bahlburg, Heino F. L.
Miller, Walter L.
Montori, Victor M.
Oberfield, Sharon E.
Ritzen, Martin
White, Perrin C.
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
title A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
title_full A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
title_fullStr A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
title_full_unstemmed A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
title_short A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
title_sort summary of the endocrine society clinical practice guidelines on congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963799/
https://www.ncbi.nlm.nih.gov/pubmed/20981249
http://dx.doi.org/10.1155/2010/494173
work_keys_str_mv AT speiserphyllisw asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT azzizricardo asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT baskinlaurences asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT ghizzonilucia asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT hensleterryw asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT merkedeborahp asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT meyerbahlburgheinofl asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT millerwalterl asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT montorivictorm asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT oberfieldsharone asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT ritzenmartin asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT whiteperrinc asummaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT speiserphyllisw summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT azzizricardo summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT baskinlaurences summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT ghizzonilucia summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT hensleterryw summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT merkedeborahp summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT meyerbahlburgheinofl summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT millerwalterl summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT montorivictorm summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT oberfieldsharone summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT ritzenmartin summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency
AT whiteperrinc summaryoftheendocrinesocietyclinicalpracticeguidelinesoncongenitaladrenalhyperplasiaduetosteroid21hydroxylasedeficiency